Error: Could not add to watchlist. X
+ Watchlist

GTx Inc

GTXI:US
NASDAQ CM
0.750
USD
0.015
1.96%
As of 8:10 PM EDT 5/26/2016
Open
0.737
Day Range
0.700 - 0.760
Volume
14,902
Previous Close
0.765
52Wk Range
0.290 - 1.590
1 Yr Return
-34.21%
Open
0.737
Day Range
0.700 - 0.760
Volume
14,902
Previous Close
0.765
52Wk Range
0.290 - 1.590
1 Yr Return
-34.21%
YTD Return
7.14%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.100
Market Cap (m USD)
106.312
Shares Outstanding (m)
141.749
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens and two essential classes of hormones. GTx is currently developing products for prostate cancer.
Address
175 Toyota Plaza
7th Floor
Memphis, TN 38103
United States
Phone
1-901-523-9700
Show More